Soluble epidermal growth factor receptor (sEGFR) and carcinoembryonic antigen (CEA) concentration in patients with non-small cell lung cancer: correlation with survival after erlotinib and gefitinib treatment.

Ecancermedicalscience · 2010 · PMC3234018 · PMID 22276032

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendp =0.06so close (0.05 < p ≤ 0.1)

Patients with sEGFR levels above 55 μg/l had a significantly longer overall survival ( Figure 1a , log rank p =0.033), while patients with a log CEA level below 1.1 showed a trend toward longer overall survival ( Figure 1b , log rank p =0.06).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.